Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2022 Results: November 9, 2021

Haemonetics Corporation (NYSE: HAE) announced the release date for its second quarter fiscal year 2022 financial results, which is set for 6:00 am EST on November 9, 2021.

Rhea-AI Summary

Haemonetics Corporation (NYSE: HAE) announced the release date for its second quarter fiscal year 2022 financial results, which is set for 6:00 am EST on November 9, 2021. The company will conduct a conference call at 8:00 am EST on the same day to discuss the results with investors and analysts. Participants can access the call via a toll-free number or an international line, with a conference ID of 3529538. A replay of the call will be available for one year starting November 9, 2021 at 11:00 a.m. EST.

Argus Publication session

+2.59% session move Open Argus

Details

News Market Reaction – HAE

In the trading session that priced this news, HAE gained 2.59%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BOSTON, Oct. 6, 2021 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish second quarter fiscal year 2022 financial results at 6:00 am EST on Tuesday, November 9, 2021. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am EST on November 9, 2021. 

The call can be accessed with the following information:

U.S. / Canada toll free (877) 848-8880; International (716) 335-9512
Conference ID required for access: 3529538

A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link: https://edge.media-server.com/m6/p/qyrbnnofhttps://edge.media-server.com/mmc/p/apntfy73

A replay of the conference call and webcast will be available for one year beginning on November 9, 2021 at 11:00 a.m. EST using the conference call webcast link provided in this press release.

ABOUT HAEMONETICS

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.  

Investor Contact:                                    Olga Guyette, Director-Investor Relations (781) 356-9763 olga.guyette@haemonetics.com

Media Contact: Josh Gitelson, Director-Global Communications (781) 356-9776 josh.gitelson@haemonetics.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-second-quarter-fiscal-year-2022-results-november-9-2021-301394550.html

SOURCE Haemonetics Corporation

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Haemonetics publish its Q2 fiscal year 2022 financial results?

Haemonetics will publish its Q2 fiscal year 2022 financial results on November 9, 2021, at 6:00 am EST.

What time is the conference call for Haemonetics' Q2 results?

The conference call for Haemonetics' Q2 results is scheduled for 8:00 am EST on November 9, 2021.

How can I access Haemonetics' Q2 financial results conference call?

You can access the conference call by calling toll-free at 877-848-8880 for U.S./Canada or 716-335-9512 for international, using conference ID 3529538.

Will there be a replay of Haemonetics' Q2 results conference call?

Yes, a replay of the conference call will be available for one year starting November 9, 2021, at 11:00 a.m. EST.

Where can I find the webcast for Haemonetics' Q2 results call?

The live webcast for Haemonetics' Q2 results call can be accessed on their investor relations website.